Asthma Treatment OTC Switches Would Face Tough Barriers
This article was originally published in The Tan Sheet
Executive Summary
Prescription asthma drugs on the brink of patent expiry could breathe new life into Rx-to-OTC switches, but not without fierce opposition from some health care providers.